Biocon

Event to focus on innovation, sustainability, and India’s growing role in the global pharma sector

This year’s ranking is based on a comprehensive web-based survey of about 6,400 respondents

Partnership aims to commercialise diabetes and weight management treatments in select Middle Eastern countries

Industry stakeholders appreciate the efforts made towards increasing employment, skill-building and implementation of various…

Kamnath is currently the Head of Business Finance R & D at Biocon

Biocon to develop and supply Liraglutide; Handok to handle regulatory approval and commercialisation in South Korea.

Biocon will undertake the responsibility of obtaining regulatory approval, manufacturing and supply of the drug product, and Medix…

Semaglutide (gOzempic), which is used to improve glycemic control in adults with type-2 diabetes

S&P Global ESG Score at 63; inducted in Dow Jones Sustainability Emerging Markets Index for third year in a row

In September, YESAFILI received marketing authorisation approval from the European Commission (EC) for the European Union (EU)